Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5

Jung Ah Lee, Byungjoon Kwon, Fernando A. Osorio, Asit K Pattnaik, Nak Hyung Lee, Sang Won Lee, Seung Yong Park, Chang Seon Song, In Soo Choi, Joong Bok Lee

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Porcine reproductive and respiratory syndrome (PRRS) causes significant economic losses to the swine industry worldwide. Although inactivated and live vaccines are commercially available for the control of PRRS, both types of vaccine have not always proven successful in terms of generating a protective immune response, particularly in the case of inactivated vaccines. In this study, we tested whether an inactivated vaccine could induce a humoral immune response to PRRS during a homologous challenge. Amino acid substitutions were introduced into glycoprotein (GP) 5 of the FL12 strain of the PRRS virus (PRRSV) using site-directed mutagenesis with a pFL12 infectious clone. The substitutions led to double deglycosylation in the putative glycosylation moieties on GP5. The mutant virus was subsequently inactivated with binary ethylenimine. The efficacy of the inactivated mutant virus was compared with that of the inactivated wild-type PRRSV. Only the inactivated mutant PRRSV induced serum neutralizing antibodies at six weeks post-vaccination. The group that was administered the inactivated mutant virus twice exhibited a significantly increased neutralizing antibody titer after a challenge with the virulent homologous strain and exhibited more rapid clearing of viremia compared to other groups, including the groups that were administered either the inactivated mutant or wild-type virus only once and the group that was administered the inactivated wild-type virus twice. Histopathological examination of lung tissue sections revealed that the group that was administered the inactivated mutant virus twice exhibited significantly thinner alveolar septa, whereas the thickness of the alveolar septa of the other groups were markedly increased due to lymphocyte infiltration. These results indicated that the deglycosylation of GP5 enhanced the immunogenicity of the inactivated mutant PRRSV and that twice administrations of the inactivated mutant virus conferred better protection against the homologous challenge. These findings suggest that the inactivated PRRSV that expresses a hypo-glycosylated GP5 is a potential inactivated vaccine candidate and a valuable tool for controlling PRRS for the swine industry.

Original languageEnglish (US)
Pages (from-to)3617-3622
Number of pages6
JournalVaccine
Volume32
Issue number29
DOIs
StatePublished - Jun 17 2014

Fingerprint

Porcine respiratory and reproductive syndrome virus
Porcine reproductive and respiratory syndrome virus
Porcine Reproductive and Respiratory Syndrome
Humoral Immunity
humoral immunity
glycoproteins
Glycoproteins
Viruses
viruses
porcine reproductive and respiratory syndrome
mutants
Inactivated Vaccines
inactivated vaccines
pork industry
Neutralizing Antibodies
neutralizing antibodies
Industry
Swine
immune response
Viremia

Keywords

  • GP5
  • Humoral immune response
  • Hypo-glycosylation
  • Inactivated virus vaccine
  • PRRSV

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5. / Lee, Jung Ah; Kwon, Byungjoon; Osorio, Fernando A.; Pattnaik, Asit K; Lee, Nak Hyung; Lee, Sang Won; Park, Seung Yong; Song, Chang Seon; Choi, In Soo; Lee, Joong Bok.

In: Vaccine, Vol. 32, No. 29, 17.06.2014, p. 3617-3622.

Research output: Contribution to journalArticle

Lee, Jung Ah ; Kwon, Byungjoon ; Osorio, Fernando A. ; Pattnaik, Asit K ; Lee, Nak Hyung ; Lee, Sang Won ; Park, Seung Yong ; Song, Chang Seon ; Choi, In Soo ; Lee, Joong Bok. / Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5. In: Vaccine. 2014 ; Vol. 32, No. 29. pp. 3617-3622.
@article{a40dc6a4de5441ee806af3429d2922e7,
title = "Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5",
abstract = "Porcine reproductive and respiratory syndrome (PRRS) causes significant economic losses to the swine industry worldwide. Although inactivated and live vaccines are commercially available for the control of PRRS, both types of vaccine have not always proven successful in terms of generating a protective immune response, particularly in the case of inactivated vaccines. In this study, we tested whether an inactivated vaccine could induce a humoral immune response to PRRS during a homologous challenge. Amino acid substitutions were introduced into glycoprotein (GP) 5 of the FL12 strain of the PRRS virus (PRRSV) using site-directed mutagenesis with a pFL12 infectious clone. The substitutions led to double deglycosylation in the putative glycosylation moieties on GP5. The mutant virus was subsequently inactivated with binary ethylenimine. The efficacy of the inactivated mutant virus was compared with that of the inactivated wild-type PRRSV. Only the inactivated mutant PRRSV induced serum neutralizing antibodies at six weeks post-vaccination. The group that was administered the inactivated mutant virus twice exhibited a significantly increased neutralizing antibody titer after a challenge with the virulent homologous strain and exhibited more rapid clearing of viremia compared to other groups, including the groups that were administered either the inactivated mutant or wild-type virus only once and the group that was administered the inactivated wild-type virus twice. Histopathological examination of lung tissue sections revealed that the group that was administered the inactivated mutant virus twice exhibited significantly thinner alveolar septa, whereas the thickness of the alveolar septa of the other groups were markedly increased due to lymphocyte infiltration. These results indicated that the deglycosylation of GP5 enhanced the immunogenicity of the inactivated mutant PRRSV and that twice administrations of the inactivated mutant virus conferred better protection against the homologous challenge. These findings suggest that the inactivated PRRSV that expresses a hypo-glycosylated GP5 is a potential inactivated vaccine candidate and a valuable tool for controlling PRRS for the swine industry.",
keywords = "GP5, Humoral immune response, Hypo-glycosylation, Inactivated virus vaccine, PRRSV",
author = "Lee, {Jung Ah} and Byungjoon Kwon and Osorio, {Fernando A.} and Pattnaik, {Asit K} and Lee, {Nak Hyung} and Lee, {Sang Won} and Park, {Seung Yong} and Song, {Chang Seon} and Choi, {In Soo} and Lee, {Joong Bok}",
year = "2014",
month = "6",
day = "17",
doi = "10.1016/j.vaccine.2014.04.083",
language = "English (US)",
volume = "32",
pages = "3617--3622",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "29",

}

TY - JOUR

T1 - Protective humoral immune response induced by an inactivated porcine reproductive and respiratory syndrome virus expressing the hypo-glycosylated glycoprotein 5

AU - Lee, Jung Ah

AU - Kwon, Byungjoon

AU - Osorio, Fernando A.

AU - Pattnaik, Asit K

AU - Lee, Nak Hyung

AU - Lee, Sang Won

AU - Park, Seung Yong

AU - Song, Chang Seon

AU - Choi, In Soo

AU - Lee, Joong Bok

PY - 2014/6/17

Y1 - 2014/6/17

N2 - Porcine reproductive and respiratory syndrome (PRRS) causes significant economic losses to the swine industry worldwide. Although inactivated and live vaccines are commercially available for the control of PRRS, both types of vaccine have not always proven successful in terms of generating a protective immune response, particularly in the case of inactivated vaccines. In this study, we tested whether an inactivated vaccine could induce a humoral immune response to PRRS during a homologous challenge. Amino acid substitutions were introduced into glycoprotein (GP) 5 of the FL12 strain of the PRRS virus (PRRSV) using site-directed mutagenesis with a pFL12 infectious clone. The substitutions led to double deglycosylation in the putative glycosylation moieties on GP5. The mutant virus was subsequently inactivated with binary ethylenimine. The efficacy of the inactivated mutant virus was compared with that of the inactivated wild-type PRRSV. Only the inactivated mutant PRRSV induced serum neutralizing antibodies at six weeks post-vaccination. The group that was administered the inactivated mutant virus twice exhibited a significantly increased neutralizing antibody titer after a challenge with the virulent homologous strain and exhibited more rapid clearing of viremia compared to other groups, including the groups that were administered either the inactivated mutant or wild-type virus only once and the group that was administered the inactivated wild-type virus twice. Histopathological examination of lung tissue sections revealed that the group that was administered the inactivated mutant virus twice exhibited significantly thinner alveolar septa, whereas the thickness of the alveolar septa of the other groups were markedly increased due to lymphocyte infiltration. These results indicated that the deglycosylation of GP5 enhanced the immunogenicity of the inactivated mutant PRRSV and that twice administrations of the inactivated mutant virus conferred better protection against the homologous challenge. These findings suggest that the inactivated PRRSV that expresses a hypo-glycosylated GP5 is a potential inactivated vaccine candidate and a valuable tool for controlling PRRS for the swine industry.

AB - Porcine reproductive and respiratory syndrome (PRRS) causes significant economic losses to the swine industry worldwide. Although inactivated and live vaccines are commercially available for the control of PRRS, both types of vaccine have not always proven successful in terms of generating a protective immune response, particularly in the case of inactivated vaccines. In this study, we tested whether an inactivated vaccine could induce a humoral immune response to PRRS during a homologous challenge. Amino acid substitutions were introduced into glycoprotein (GP) 5 of the FL12 strain of the PRRS virus (PRRSV) using site-directed mutagenesis with a pFL12 infectious clone. The substitutions led to double deglycosylation in the putative glycosylation moieties on GP5. The mutant virus was subsequently inactivated with binary ethylenimine. The efficacy of the inactivated mutant virus was compared with that of the inactivated wild-type PRRSV. Only the inactivated mutant PRRSV induced serum neutralizing antibodies at six weeks post-vaccination. The group that was administered the inactivated mutant virus twice exhibited a significantly increased neutralizing antibody titer after a challenge with the virulent homologous strain and exhibited more rapid clearing of viremia compared to other groups, including the groups that were administered either the inactivated mutant or wild-type virus only once and the group that was administered the inactivated wild-type virus twice. Histopathological examination of lung tissue sections revealed that the group that was administered the inactivated mutant virus twice exhibited significantly thinner alveolar septa, whereas the thickness of the alveolar septa of the other groups were markedly increased due to lymphocyte infiltration. These results indicated that the deglycosylation of GP5 enhanced the immunogenicity of the inactivated mutant PRRSV and that twice administrations of the inactivated mutant virus conferred better protection against the homologous challenge. These findings suggest that the inactivated PRRSV that expresses a hypo-glycosylated GP5 is a potential inactivated vaccine candidate and a valuable tool for controlling PRRS for the swine industry.

KW - GP5

KW - Humoral immune response

KW - Hypo-glycosylation

KW - Inactivated virus vaccine

KW - PRRSV

UR - http://www.scopus.com/inward/record.url?scp=84901604609&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901604609&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2014.04.083

DO - 10.1016/j.vaccine.2014.04.083

M3 - Article

C2 - 24814552

AN - SCOPUS:84901604609

VL - 32

SP - 3617

EP - 3622

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 29

ER -